- Investigator
- Paul Castillo
- Status
- Accepting Candidates
About me
Paul Castillo, M.D., is an Assistant Professor of Pediatrics and physician-scientist of the T Cell Engineering Laboratory of the Pediatric Cancer Immunotherapy Initiative (PCI2) and the Brain Tumor Immunotherapy Program (BTIP) at the University of Florida (UF). He serves as a member of the UF Data Integrity and Safety Committee (DISC), UF College of Medicine Scientific Review Committee, and as liaison of the UF Health Cancer Center Community Outreach Engagement Council.
He received his medical degree from the Universidad Peruana Cayetano Heredia, Lima, Peru. He completed his pediatric residency at the Riley Hospital for Children – Indiana University. Next, he trained in hematology-oncology with additional focus on stem cell transplantation and cellular therapy at the Texas Children’s Cancer and Hematology Centers – Center for Cell & Gene Therapy – Baylor College of Medicine. At the University of Florida, his translational efforts are focused on developing new pipeline technologies that include systemic activation of innate and adaptive immunity to synergize and enhance CAR T cell activity against metastatic osteosarcoma. His research has received multiple awards including the Hyundai Hope On Wheels Young Investigator award, the American Brain Tumor Association Discovery award, the Florida Department of Health Live Like Bella Discovery award, the Gabrielle’s Angel Cancer Research Foundation award, and an institutional KL2 award. His research endeavors are additionally supported by the STOP Children’s Cancer, Inc.
My locations
Active clinical trials
This is a Phase 2 study to evaluate posoleucel (ALVR105, formerly Viralym-M); an allogeneic, off-the-shelf multi-virus specific T cell therapy that targets six viral pathogens: BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human…
- Investigator
- Paul Castillo
- Status
- Accepting Candidates
- Ages
- 1 Year - N/A
- Sexes
- All
This study will assess the safety and efficacy of Posoleucel for the treatment of adenovirus (AdV) infection in pediatric and adult allo-HCT recipients receiving standard of care (SoC).
- Investigator
- Paul Castillo
- Status
- Accepting Candidates
- Ages
- N/A - N/A
- Sexes
- All
My research
Top areas of exploration
- Leukemia, Myeloid, Acute , 2 publications
- Myelodysplastic Syndromes , 2 publications
- Mutation , 1 publications
- Precision Medicine , 1 publications
Research activity
Search our accepted insurances list
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
My areas of focus
Stories and news
Lyrics for Life boosts UF Health pediatric cancer research
August 24, 2023
Pediatric cancer research will get a boost, thanks to a gift to the University of Florida College of Medicine from a band with local roots. The Lyrics for Life…
College of Medicine, UF Health Cancer Center, +2 more
